GLYCOPYRRONIUM TOSYLATE
| Brand name | QBREXZA |
|---|---|
| Active ingredient | GLYCOPYRRONIUM TOSYLATE |
| Strength | EQ 2.4% BASE |
| Dosage form | CLOTH |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | June 2018 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10543192 | February 2033 | product |
| 8859610 | February 2033 | product |
| 9259414 | February 2033 | use U-2398 |
| 10004717 | February 2033 | product |
| 10548875 | February 2033 | substance, product |
| 9744105 | July 2030 | product |
| 8618160 | December 2029 | product |
| 10052267 | October 2028 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.